Ivermectin/Pyrantel Chew. Dog 136Mcg/114Mg

Verify with FDA CVM →

541 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
541
Total Reports
2
Deaths Reported
40.0%
Death Rate

Active Ingredients

Ivermectin/Pyrantel Chew. Dog 136Mcg/114Mg

Administration Routes

OralUnknownSubcutaneous

Species Affected

Dog 477
Unknown 63
Human 1

Most Affected Breeds

Crossbred Canine/dog 101
Unknown 64
Beagle 53
Retriever - Labrador 42
Dog (other) 25
Collie - Border 15
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 13
Retriever - Golden 13
Hound - Basset 11
Spaniel - Cocker American 11

Most Reported Reactions

Digestive tract disorder NOS 265
INEFFECTIVE, HEARTWORM LARVAE 199
Cardiac disorder NOS 133
Lack of efficacy (endoparasite) - hookworm 128
INEFFECTIVE, ASCARIDS NOS 110
No sign 58
Lack of efficacy - NOS 46
Tablets, Abnormal 32
Vomiting 31
Containers, Damaged 28
Diarrhoea 23
Lack of efficacy (protozoa) - Coccidia 13

Outcome Breakdown

Outcome Unknown
312 (64.9%)
Recovered with Sequela
131 (27.2%)
Recovered/Normal
31 (6.4%)
Ongoing
5 (1.0%)
Died
2 (0.4%)

Data Summary

Metric Value
Total adverse event reports 541
Reports involving death 2
Case-fatality rate (reported events) 40.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin/Pyrantel Chew. Dog 136Mcg/114Mg Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 541 adverse event reports referencing Ivermectin/Pyrantel Chew. Dog 136Mcg/114Mg, including 2 reports in which the animal died — a 40.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin/Pyrantel Chew. Dog 136Mcg/114Mg. Reported administration routes include Oral, Unknown, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin/Pyrantel Chew. Dog 136Mcg/114Mg reports are Dog (477 reports), Unknown (63 reports), Human (1 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (101), Unknown (64), Beagle (53) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin/Pyrantel Chew. Dog 136Mcg/114Mg are Digestive tract disorder NOS (265), INEFFECTIVE, HEARTWORM LARVAE (199), Cardiac disorder NOS (133), Lack of efficacy (endoparasite) - hookworm (128). Of the 481 reports with a coded outcome, Outcome Unknown is the leading category at 64.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin/Pyrantel Chew. Dog 136Mcg/114Mg.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial